CLSA backs MBO of Japan medical IT systems supplier

Financial terms were not disclosed. CLSA CP made the investment through the latest fund Sunrise Capital III, which closed at $400 million in 2017. The vehicle seeks buyouts of companies valued at JPY5-15 billion ($47-141 million). NHOSA will retain its corporate structure and name following the transaction.  

Established in 1979, the Tokyo-headquartered company develops and maintains medical information processing systems. Its flagship EHR product - Wise Staff 9 Plus - claims to optimize operational efficiency at dental clinics by simultaneously preparing electronic and printed receipts.

NHOSA serves 10,000 customers through 13 directly-owned branches and a network of distributors, generating approximately JPY4.6 billion in revenue last year. CLSA will support the company to expand its product lines and services by leveraging the GP’s broad network and management experiences.

“Sunrise III regards NHOSA as a top player in the niche dental clinic-focused EHR system industry. The quality of the products and after-care services along with the company’s strong sales capabilities are of the highest standards within the industry," said Megumi Kiyozuka, a managing director at CLSA CP, in a statement. "Their stable client base is also equally highly attractive, and we believe there is potential to further increase market share." 

This is CLSA CP's fourth Japan investment this year, following beauty salon chain Agu Group, uniform rental business Marubeni Mates, and household appliances online retailer Moa Group. Existing portfolio company Outsourcing Investments also completed the bolt-on acquisition of advanced industrial services player HamaEngineering.

• Tweet  
• Facebook  
• LinkedIn  
• Google plus  
• Save this article  
• Send to  

• Topics
• North Asia
• Buyouts
• Support services
• Technology
• Japan
• CLSA Capital Partners
• manufacturing
• healthcare